Botox Approved to Treat Spasticity in 8 New Arm, Hand Muscles

Botox Approved to Treat Spasticity in 8 New Arm, Hand Muscles

301418

Botox Approved to Treat Spasticity in 8 New Arm, Hand Muscles

The U.S. Food and Drug Administration (FDA) has expanded the label for Botox (onabotulinumtoxinA) in adults for the treatment of upper limb spasticity — a common symptom of multiple sclerosis (MS) — to include eight more muscles. The new approval will allow Botox to be used to treat spasticity in the arms and hands of people with MS. “Today’s announcement is especially important because spasticity is a disabling neurological condition that can have a significant…

You must be logged in to read/download the full post.